Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.03
Delayed Data
As of 4:00pm ET
 -0.03 / -0.98%
Today’s Change
2.65
Today|||52-Week Range
5.70
-24.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-17.3M-18.0M5.5M-41.3M
 
 
 
 
 
Depreciation358.4K674.7K857.1K886.7K
 
 
 
 
 
Total Other Cash Flow5.1M7.3M9.6M8.3M
 
 
 
 
 
Funds From Operations-11.9M-10.1M16.0M-32.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-101.1M41.0M58.2M128.1K
 
 
 
 
 
Net Cash Flow - Operating Activities89.2M-51.1M-42.2M-32.2M
 
 
 
 
 
 
InvestingIncrease In Investments-265.2M-125.0M-149.4M-86.3M
 
 
 
 
 
Decrease In Investments163.7M195.1M82.3M88.1M
 
 
 
 
 
Capital Expenditures-1.9M-827.8K-1.5M-341.6K
 
 
 
 
 
Fixed Asset Disposal----10.0K0.00
 
 
Net Cash Flow Investing-103.4M69.3M-68.6M1.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-13.5M0.000.000.00
 
 
Net Proceeds Stock Sale0.00644.9K103.5M684.3K
 
 
 
 
Common Preferred Redeemed0.000.00-3.8K-57.3K
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing391.4K0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-13.2M644.9K103.5M627.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash707.00-6.8K-38.8K-1.4K
 
 
 
 
 
 
Net Change In Cash-27.4M18.9M-7.3M-30.1M